Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results

Marinus Pharma (MRNS) Misses Q4 EPS by 4c, Revenues Beat

March 9, 2021 7:18 AM EST

Marinus Pharma (NASDAQ: MRNS) reported Q4 EPS of ($0.55), $0.04 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.55 million versus the consensus estimate of $1.04 million.

Although 2020 was extremely challenging for so many, we finished the year achieving several important milestones, which has provided momentum into 2021, said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. We remain on track to submit a new... More